A study of MVA-BN-RSV Vaccine.
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2016
At a glance
- Drugs MVA-BN RSV (Primary)
- Indications Respiratory syncytial virus infections
- Focus Therapeutic Use
- 02 Nov 2016 According to a Bavarian Nordic media release, this study is planned for initiation later in 2017.
- 02 Nov 2016 New trial record